Switching within the class of IL-17 inhibitors for the treatment of plaque psoriasis: A real-world retrospective study

Australas J Dermatol. 2024 Dec 12. doi: 10.1111/ajd.14396. Online ahead of print.

Authors

Ioannis-Alexios Koumprentziotis¹, Natalia Rompoti¹, Irene Stefanaki¹, Charitomeni Vavouli¹, Marina Papoutsaki¹, Maria Politou¹, Alexander Stratigos¹, Electra Nicolaidou¹

Affiliation

¹ 1st Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, "A. Sygros" Hospital for Skin and Venereal Diseases, Athens, Greece.

PMID: 39665153
DOI: 10.1111/ajd.14396

No abstract available

Keywords: Il‐17 inhibitors; bimekizumab; biologics; intraclass switch; psoriasis.